All posts by imreal

Aveda Arts & Sciences Institutes Win Two BeautyMatter NEXT Awards for Textured Hair Education Initiative


Edwin Neill, the CEO of Aveda Arts & Sciences Institutes and President of the Neill Corporation, was awarded the Changemaker of the Year award for his unrelenting advocacy for textured hair education and diversity in the beauty industry. Neill is a frequent speaker on this topic and has worked with many state officials for more inclusive licensing support. In his current role as the Chairman of the Louisiana Board of Cosmetology, he was instrumental in the state including textured haircare on the state licensing exam, thereby requiring all cosmetology schools in the state to include it in their curriculum. This change cemented Louisiana’s place in the history books as the first state to require textured hair education (NPR). Now, other states are following suit.

“We are honored to receive these awards from BeautyMatter, an important media voice in our industry,” said Neill. “They are a testament to our commitment to diversity, equity, and inclusion, and to our mission of providing the highest quality education to our students. We are proud to be a force for good in the world.”

For more information on Aveda Arts’ commitments towards furthering textured hair education in America, read BeautyMatter’s story, “AVEDA ARTS & SCIENCES INSTITUTES LEAD THE NEXT WAVE OF TEXTURED HAIR EDUCATION.”

About Aveda Arts & Sciences Institutes
Aveda Arts & Sciences Institutes is a leading provider of beauty and wellness education. The company offers a variety of programs, including cosmetology, esthetics, massage therapy, and nail care. Aveda Arts & Sciences Institutes is committed to preparing students with the skills and knowledge they need to excel in the beauty industry. Follow at @avedaarts.

About BeautyMatter
BeautyMatter is a leading online platform for the beauty industry. The outlet provides a range of resources for beauty professionals, including articles, videos, and webinars. BeautyMatter also hosts a number of events throughout the year, including the annual BeautyMatter NEXT Awards. Follow them at @BeautyMatterOfficial.

Media Contact

Julia Labaton, RED PR LLC, 646-528-3969, [email protected], www.red-pr.com

Twitter

SOURCE Aveda Arts & Sciences Institute



Evidence Mounts in Support of C15:0 as a Core Nutrient To Enhance Longevity


Seraphina Therapeutics Founder shows essential nutrient rivals leading anti-aging drugs in clinically relevant benefits expected to extend human longevity.

SAN DIEGO, Oct. 30, 2023 /PRNewswire-PRWeb/ — A recently published study in the scientific journal Nutrients reveals that C15:0 (pentadecanoic acid), an odd-chain healthy saturated fat found in trace amounts in dairy fat, and the first essential fatty acid to be discovered in over 90 years (since omega-3), has anti-aging properties expected to extend human longevity that equal, and even surpass, leading prescription drug candidates.

While numerous studies have linked higher C15:0 levels to lower risks of type 2 diabetes, heart disease, nonalcoholic fatty liver disease, and cancer, only recently have the anti-aging mechanisms driving these C15:0 health benefits been revealed.

“In 2020, we discovered that C15:0 directly targets multiple hallmarks of aging and effectively repaired cells throughout the human body,” said Dr. Stephanie Venn-Watson, co-founder of Seraphina Therapeutics and the lead author of the recent Nutrients paper and earlier ‘Nature’s Scientific Reports‘ paper. “Paired with the mounting science on C15:0’s long-term health benefits, we hypothesized that this nutrient plays an essential role in supporting human longevity. We were delighted by the study’s results.”

In the recent study, pure C15:0 (FA15) went head-to-head against three leading longevity drug candidates: rapamycin, metformin, and acarbose. Independent, third-party tests of all four compounds were conducted and evaluated for dose-dependent effects on clinically relevant biomarkers across 12 human cell systems mimicking various chronic disease states.

Of the four compounds, the results showed that pure C15:0 delivered the most cell repairing benefits, closely followed by rapamycin. At their optimal doses, C15:0 and rapamycin shared an impressive 24 clinically relevant activities across 10 out of the 12 human cell systems evaluated. These benefits, including anti-inflammatory, anticancer, antifibrotic, and antimicrobial activities of both C15:0 and rapamycin, align well with previously published studies. C15:0 and rapamycin have also been shown to share the ability to inhibit mTOR, which has been targeted as a key means to extend human longevity.

Dr. Nicholas Schork, the study’s co-author and Principal Investigator for the National Institutes of Health’s Longevity Consortium, points out that “the numerous benefits of C15:0, that match and even surpass that of leading candidate longevity drugs, speak to the essentiality of C15:0 to our long-term health.” Dr. Schork shares, “Remarkably, while billions of dollars have been spent around the world on advancing anti-aging research, the secret to longevity may be much closer to home.”

As a particularly urgent point, population-wide C15:0 levels have been declining, caused by avoidance of whole fat cow’s milk over the past 40 years. Given its role as an essential nutrient, it is hypothesized that nutritional C15:0 deficiencies may be driving the rise in chronic diseases among younger people, including nonalcoholic fatty liver disease (NAFLD). The most recently discovered longevity-enabling activities of C15:0 suggests that nutritional C15:0 deficiencies may help explain why human lifespans have been shortening over recent years, too.

“While global health has been declining at an alarming rate, studies are increasingly supporting that we have a new and tangible hope – the ability to readily replenish our C15:0 levels, restore aspects of our long-term health, and extend longevity for all,” states Venn-Watson.

************************************************************
About Seraphina Therapeutics. Inc.
Seraphina Therapeutics, Inc. is a health and wellness company dedicated to advancing global health through the discovery of essential fatty acids and micronutrient therapeutics. Through rigorous breakthrough science, the company develops fatty acid supplements, food fortifiers, and nutritional interventions to strengthen cells, keep mitochondria working and advance cellular homeostasis to counter age-related breakdown. With its team of industry-leading scientists, Seraphina Therapeutics challenges long-held approaches to nutrition, enabling the creation of novel health products designed to support quality of life. For more information, please visit DiscoverC15.com and fatty15.com.

Media Contact

Fatty15 Press Office, Seraphina Therapeutics, 619-407-9225, [email protected], fatty15.com

SOURCE Seraphina Therapeutics

Catholics for Choice Statement on the Conclusion of the First Meeting of the Synod on Synodality


“For the first time in the modern era, the Catholic church held conversations about previously taboo topics like ordaining women, recognizing the relationships of LGBTQIA+ people, and rethinking church power structures.  We join our partners in the women’s ordination and LGBTQIA+ justice movements in expressing our deep concern about the synod’s failure to take seriously the grave injustice of gender equality and its refusal to acknowledge the longings of LGBTQIA+ Catholics for a more inclusive church. 

“The church’s harmful teachings on gender and LGBTQIA+ people have profound intersections with its position on reproductive health and rights. So the synod’s continued silence on abortion — which touches the lives of far more Catholics than any of these other urgent issues — shows just how powerful and pervasive abortion stigma remains in our church. 

“If Pope Francis is serious about his call to encounter each other across lines of difference, then we must talk openly and honestly about abortion, acknowledge its moral complexities, and listen to the wisdom and lived experiences of the many faithful Catholics who have abortions. That’s why I went to Rome to share the stories of Catholics for Choice who have had abortion care. The church cannot be open to the workings of the Holy Spirit on some issues while silencing conversation on others. The synod may be over for now, but the church’s work is far from finished.”

To ensure that pro-choice Catholics would not be silenced at the synod, Catholics for Choice brought our message to Rome in a series of dramatic and powerful acts:

  •     CFC President Jamie Manson and supporters unfurled a massive banner on a bridge along the primary pathway to the Vatican, boldly proclaiming the truth that “Faithful Catholics have abortions.” (Photos, press release)
  •     Immediately afterwards, Jamie processed to the synod office to hand-deliver a booklet of abortion stories collected from faithful Catholics, in what the New York Times described as a “mission impossible.” Catholics for Choice was turned away on our first attempt, but Jamie returned a week later and successfully completed the delivery. (video, video)
  •     Jamie Manson spoke at the Spirit Unbounded conference — a gathering of reform-minded advocates for human rights in the Catholic church — alongside fellow Catholic luminaries like author Sr. Joan Chittister and former Irish president Mary McAleese. Just a few steps from the Vatican, she called out the pastoral crisis of radical patriarchy in the church and issued this challenge to her fellow queer Catholics and supporters of women’s ordination:

“None of us will have true justice in our church until… patriarchal notions of gender are dismantled… [W]e are all being oppressed by the same ideology. Throwing each other under the bus because we think our particular community is getting somewhere with this pope is a deeply flawed strategy. We have to fight for each other, because we either all get justice together by dismantling this ideology once and for all, or there will be no true justice for any of us.” (Full speech available here.)

Catholics for Choice will continue to monitor the activities of the U.S. Conference of Catholic Bishops at their fall gathering on November 13-16, 2023, and the Synod on Synodality will meet for a second and final session in October 2024.

Catholics for Choice shapes and advances sexual and reproductive ethics that are based on justice, reflect a commitment to a person’s well-being and respect, and affirm the capacity of all people to make moral decisions about their lives.

Media Contact
John Becker, Catholics for Choice, 202-203-0931, Press Secretary, [email protected], www.catholicsforchoice.org

SOURCE Catholics for Choice

Completion of Haven at Mansfield Near Dallas, TX Adds 257 Luxury Apartment Homes to Ascendant’s Growing Texas Portfolio


Ascendant completed construction and began leasing the project in July 2023. “Haven at Mansfield is already 35% preleased at rents well above proforma and on track for a very successful lease-up,” stated Richard Owen, Principal. “Young professionals in particular have shown a strong interest in the luxury 4-story product type, with air-conditioned interior corridors and A+ luxury finishes.”

Haven at Mansfield Overview
The community, consisting of three 4-story residential buildings, including an expansive clubhouse, was planned and designed by EDI International. The apartments range in size from 634 square feet to 1,270 square feet and feature luxury vinyl plank flooring, energy efficient LED lighting, granite countertops, kitchen backsplashes, undermount sinks and stainless appliances.

The project’s amenity suite includes a gourmet kitchen, interior garages, fitness center and yoga/spin room, game room, clubroom, expansive lobby, green paseo, and resort-style saltwater pool.

About Ascendant Development
Ascendant Development is a privately owned vertically integrated real estate investment, development and construction company focused on originating attractive risk return investment opportunities though designing and constructing luxury Class A multifamily and student housing properties throughout the United States. See more at: http://www.ascendantdevco.com. 

Media Contact
Luci Peterson, Serendipit Consulting, 2086705618, [email protected], www.serendipitconsulting.com

SOURCE Ascendant Development

American HFC Coalition Applauds the U.S. Department of Commerce for Initiating an Investigation Into Unlawful Circumvention of U.S. Law by Imports of HFC Refrigerant R-410B from Mexico


WASHINGTON, Oct. 30, 2023 /PRNewswire/ — The American HFC Coalition applauds the U.S. Department of Commerce for initiating an anti-circumvention inquiry to determine whether imports of Chinese hydrofluorocarbons (HFCs) are circumventing the 2016 antidumping duty order on HFC blends….

Dental Care Alliance Enters State of Rhode Island as it Welcomes Hodosh Cosmetic & Implant Dentistry


The practice is dedicated to offering the finest oral healthcare solutions using advanced technologies and materials. Dr. Alex Hodosh takes great care in developing each individual’s treatment plan based on their specific needs, emphasizing lasting dental health, function, and beauty. Dr. Hodosh believes that listening and connecting with his patients affords him the ability to truly understand their needs and tailor their treatment to them individually. He takes enormous pride in providing the finest care for his patients and believes that improving their dental health has a lasting positive impact on their quality of life.

Exceptional patient care and cutting-edge treatment are part of Hodosh Cosmetic & Implant Dentistry’s history. The practice was founded by Dr. Milton Hodosh who was a pioneer in the field of dental implants. His research, which included eleven National Institute of Health grants, established the basic principles for the development and success of dental implants. He was a prolific inventor and holder of over 40 US and foreign patents. In addition, he isolated, developed, and patented the key chemical formula for the treatment of dental hypersensitivity, which is now the essential ingredient for the leading desensitizing toothpastes worldwide. His sons, Drs. Steven and Alex Hodosh followed in his footsteps and continued to expand the practice with the most modern and up-to-date technology.

Dr. Alex Hodosh has practiced dentistry for over 35 years and still feels honored and happy to be welcomed into people’s lives. Dr. Hodosh attended Boston University, receiving a bachelor’s degree in Biology, and then went on to Tufts University School of Dental Medicine where he earned a Doctor of Dental Medicine in 1987. Dr. Hodosh also completed specialty training in Dental Implantology at the Brookdale Hospital in New York. Dental Implants have been integrated into his daily practice for the past 35 years.

Dr. Hodosh remains very active in dental advancements, presenting and lecturing at professional conferences and meetings on implant placement techniques and restoration. In addition, Dr. Hodosh is an expert in utilizing 3D technology for the treatment planning and guided surgical placement of implants. He has been an early adopter of many high-tech advancements in dental technology. He is highly skilled in the use of the CEREC 3D system for the design and fabrication of crown and bridge and implant procedures and specializes in providing same-day dentistry using these modern tools.

Dr. Hodosh grew up in Providence and has been a Rhode Island resident his entire life. When not in the office, he prioritizes time with his family and particularly enjoys engaging with his children’s various interests and activities. He also values quality time with friends and enjoys fishing and skiing. Dr. Hodosh is a big believer in giving back to the community: helping the homeless as well as supporting local youth softball leagues, local libraries, and neighborhood churches.

“I have practiced dentistry for over 35 years and still feel honored and happy to be welcomed into people’s lives, and likewise I feel honored to be welcomed into the DCA family,” shared Dr. Alex Hodosh. “I am excited for the future with this DCA partnership, and I look forward to continuing to bring to life the exceptional care and forward-looking dentistry that has been the cornerstone of my practice.”

Practicing alongside Dr. Alex Hodosh is Dr. Daniel Son. Dr. Son believes that dentistry is a way to help people lead healthier, happier, more enjoyable lives. Whether he’s providing a checkup, brightening a smile, relieving pain, or restoring function, my focus is always on what is right for the individual: he wants them to have a worry-free experience and be pleased with the results.

Dr. Son appreciates how every procedure is a combination of art, science, and personal connection. The conversations with patients, prior to designing their treatment, are key to providing optimal care. He especially enjoys educating people on their oral health, explaining what’s happening in their mouth, and how together they can address the situation.

Dr. Son completed a Bachelor of Science in Chemistry in 2010, at Carnegie Mellon University and then attended Columbia University, where he was awarded a Doctor of Dental Surgery and a Master of Arts in Science and Dental Education in 2015. Dr. Son also attended Harvard University from 2015-2018 to pursue a Master of Medical Sciences in Oral Biology and Certificate in Prosthodontics.

Both doctors strive to always provide the highest quality in clinical care, which they deliver with gentle hands, to ensure the best results. They are experienced, professional, and friendly, always aiming to make every interaction and each procedure as comfortable as possible.

This affiliation continues the rapid growth and momentum of the organization and expands DCA’s footprint into the state of Rhode Island. DCA’s total footprint includes over 400 allied practices across the US.

“Hodosh Cosmetic & Implant Dentistry occupies an important place in the history of dentistry,” shared Andrew Clarke, DCA Vice President Business Development. Dr. Hodosh and Dr. Son are exceptional doctors, and I’m excited DCA can help support them in continuing the practice’s legacy. We couldn’t be more thrilled to have them partner with DCA, along with the practice’s talented, dedicated staff.”

Dental Care Alliance’s mission is to advance the practice of dentistry by partnering with and supporting dental professionals to create a lifetime of healthy smiles. DCA currently supports over 400 allied practices and over 900 dentists across 23 states. DCA’s allied practices represent all dental specialties and treat patients under more than 150 brand names.

Media Contact

Molly Benz, Dental Care Alliance, 9419553150, [email protected], dentalcarealliance.com

SOURCE Dental Care Alliance

Phoenix-Based Developer Sells Single-Family Rental Home Community For $25.6 Million


Curve’s single-family home design features controlled access entry, attached two-car garage, fully-fenced private backyard with maintenance-free landscaping, and high-end interior finishes. Every home offers SMART Technology which includes a control panel, doorbell, front door deadbolt, thermostat, and a motion sensor.

“Curve Development is proud to develop single family rental communities across the U.S. This is our second sale in the Phoenix market, and it once again shows the tremendous value in the market for the high quality leased-living experience. We know our Cyrene communities provide a highly desirable alternative to a homeownership,” said Nathan Pile, president, and owner of Curve Development.

Cyrene at Estrella offers an on-site dog park, community playground, community lawn space and grilling area, top-rated nearby schools, world-class golf courses, easy access to community parks and numerous shopping and retail centers. The modern home design and unique architecture include hardwood-inspired plank flooring, entertainment-style kitchen islands, stainless steel appliances, quartz kitchen countertops, and artisan front doors. The single-family rental community offers the benefits and privacy of a detached home without the stresses of homeownership.

The community comprises both three- and four-bedroom detached home options with internet service included in rent. The community is pet-friendly and is minutes from Estrella Mountain Regional Park and the Goodyear Ballpark spring training baseball facility.

The developer sold its Cyrene at South Mountain single family rental community in October 2022. The 72-home community sits on 8.9 acres and closed for $35.5 million, garnering $493,000 per door – a milestone transaction for the area.

Curve currently holds three other built-to-rent communities in the company’s portfolio, with five new communities in the pipeline.

Find out more about Curve Development on Facebook, Instagram, and LinkedIn.

About Curve Development
Curve Development, a national developer/builder based in Arizona developing single-family rental projects coast to coast, is funded by JEN Partners, LLC, a New York-based private equity fund. Over the past eight years, Curve’s Principal has built a long-standing relationship with JEN Partners. Curve is strategically positioned to offer a wide variety of investment opportunities on a national scale. Curve has financial resources and regional land partnerships to acquire and develop sites without the typical developer challenges. The company’s seasoned team of industry professionals and the JEN family of regional land developers has positioned Curve as an incomparable partner in real estate development with the agility, creativity and strength to create virtually limitless value. To learn more, visit https://curvedevelopment.com/

Media Contact
Luci Peterson, Serendipit Consulting, 2086705618, [email protected], www.serendipitconsulting.com

SOURCE Curve Development

Balluff Grand Opening of Production Facility in Aguascalientes, Mexico


Creating perspectives
As a fourth-generation family business, Balluff plans ahead. “One of the guiding principles at Balluff is: we think and act today for tomorrow,” explains Nonnenmann. “Our strategies are always future-oriented – in terms of economic efficiency and the environment, technology and product quality, but above all in terms of the people in our company. In this way, we can offer our employees and our business partners and customers a long-term and sustainable perspective.” Anyone who starts at Balluff can make a career here.

The company’s management is also local – Edgar Gonzalez, who has called Aguascalientes home for many years, leads the new operation site. Currently, Balluff has 70 employees in Aguascalientes, but that number will increase quickly. The plan is to have 100 people on the team by the end of the year – and 700 by 2027 at the latest. Balluff offers modern working environments, the latest production technology, and an energy-efficient technical infrastructure. The installation of a 500 kWp photovoltaic system on the roof of the production and logistics hall is underway. This will enable the site to cover about a third of its needs with its own electricity in the future. Balluff expects to save around 350 tons of carbon dioxide per year.

Steady expansion and strong team spirit
Following the successful start of production, Balluff will gradually expand manufacturing in Aguascalientes: Additional assembly lines for sensor and network technology for the American market will follow. Gonzalez is looking forward to the new tasks and is confident of a smooth production start-up: “In the past months, we have already been able to experience how well the international cooperation between the various Balluff locations works and we have benefitted from the experience of our colleagues.” Teams of experts from Hungary, China, and Germany trained the employees in Mexico before the start of production. Gonzalez emphasizes, “Our colleagues have worked very hard for us. We clearly felt the special Balluff family spirit: everyone working together.”

Balluff is starting in Aguascalientes with a production area of 7,000 m² and the option to expand this if required. The space for this has already been reserved. For the sensor and automation specialist, the establishment of the Mexican production site is a milestone and just one of several major projects this year – Balluff is significantly optimizing its own production network this year. In addition to the Aguascalientes project, the company has significantly expanded its production sites in Veszprém, Hungary, and Chengdu, China. With the expansion of production capacities in three regions, Balluff is creating the conditions for more stable global supply chains, shortened delivery times, and advanced sustainability.

About the company Balluff
Founded in 1921 in Neuhausen a. d. F., Balluff with its 3900 employees worldwide stands for innovative technology, quality, and cross-industry experience in industrial automation. As a leading sensor and automation specialist, the fourth-generation family-owned company offers a comprehensive portfolio of high-quality sensor, identification, network, and software solutions.

In 2022, the Balluff Group recorded sales of around 567 million euros. In addition to its central headquarters in Neuhausen a. d. F., Balluff has sales, production, and development locations around the globe and is represented by 38 subsidiaries and other agencies in 61 countries. This guarantees customers fast worldwide availability of products and a high quality of advice and service directly on-site.

Media Contact

Juli Hale, Balluff, 18005438390, [email protected], https://www.balluff.com/

SOURCE Balluff